Inhibrx Biosciences (INBX) Earnings Date
The next earnings date for Inhibrx Biosciences (INBX) is around Mar 18, 2027, estimated from its own calendar.
- Next earnings date
- Around Mar 18, 2027
- estimated from its own calendar · quarter ending Dec '26
- Latest stored quarter
- EPS −2.46
- revenue $2.0M · reported Nov 13, 2026
Does this company deliver against its own promises? Earnings are a check on the thesis, not a catalyst to chase.
0 of 2 scored quarters beat.
| Report | Est EPS | Act EPS | Surprise | Est rev | Act rev | Rev surp. | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 13, 20268-K, after close · 4:02 pm ET | −2.45 | −2.46 | −0.5% | $1.9M | $2.0M | +5.3% | −6.8%next session |
| Aug 13, 2026 filed | −2.28 | −2.34 | −2.6% | $0.00 | $0.00 | — | —filing date only |
| May 14, 20268-K, after close · 4:04 pm ET | — | −2.15 | — | — | $0.00 | — | −6.5%next session |
| Mar 19, 20268-K, after close · 4:01 pm ET | — | −2.11 | — | — | — | — | −6.1%next session |
| Nov 13, 20258-K, after close · 6:00 pm ET | — | −2.28 | — | — | $0.00 | — | +6.0%next session |
| Aug 13, 20258-K, after close · 4:06 pm ET | — | −1.85 | — | — | $1.3M | — | +1.6%next session |
| May 14, 20258-K, after close · 4:11 pm ET | — | −2.80 | — | — | $0.00 | — | +10.9%next session |
| Mar 17, 20258-K, after close · 4:09 pm ET | — | −4.25 | — | — | $100,000.00 | — | +0.4%next session |
Estimate-vs-actual scoring began Jul 2026 and is still accruing: 2 of the 8 quarters above carry a scored estimate. We never backfill an estimate we didn't observe.
filed marks a quarter where we found no results release and hold only the date its report was filed. A filing can trail the release by days or weeks, so those rows show no reaction rather than the move of an unrelated session.
| Measure | Dec '26 | Mar '27 | FY26 | FY27 |
|---|---|---|---|---|
| No. of analysts | 2 | 1 | 1 | 2 |
| Avg estimate | −2.68 | −2.37 | −9.56 | −8.78 |
| Low estimate | −3.24 | −2.37 | −10.50 | −9.58 |
| High estimate | −2.11 | −2.37 | −8.62 | −7.96 |
| Year-ago EPS | −2.11 | −2.15 | −9.04 | −9.56E |
| Implied growth | — | — | — | — |
| Measure | Dec '26 | Mar '27 | FY26 | FY27 |
|---|---|---|---|---|
| No. of analysts | 1 | 1 | 1 | 2 |
| Avg estimate | $2.4M | $1.2M | $666,667.00 | $32.0M |
| Low estimate | $2.4M | $1.2M | $435,246.00 | $19.6M |
| High estimate | $2.4M | $1.2M | $908,066.00 | $44.3M |
| Year-ago revenue | — | $0.00 | $1.3M | $666,667.00E |
| Implied growth | — | — | −48.7% | +4692.9% |
| Snapshot age | Dec '26, period ending Dec 30, 2026 | Mar '27, period ending Mar 30, 2027 | FY26, period ending Dec 31, 2026 | FY27, period ending Dec 31, 2027 |
|---|---|---|---|---|
| Current estimate | −2.68 | −2.37 | −9.56 | −8.78 |
| 7 days ago | −2.70 | — | −9.52 | −8.94 |
| 30 days ago | −2.70 | — | −9.52 | −8.94 |
| 60 days ago | −2.70 | — | −9.52 | −8.94 |
| 90 days ago | −2.87 | — | −9.65 | −7.80 |
Estimate history accrues from our nightly snapshots. The 7/30/60/90-day rows fill in as tracking continues. Each column follows one fiscal period back through our snapshots; a dash means we had not recorded that period at that age. A rising bar makes a beat streak more meaningful; a falling one manufactures beats.
Dec '26 quarter consensus moved $−2.87 → $−2.68 over 90 tracked days, the same quarter at both ends. Per-analyst up/down revision counts aren't in our data feed. We show the bar's actual movement instead of guessing.
Common questions
When does Inhibrx Biosciences report earnings next?
Inhibrx Biosciences' next earnings date is around Mar 18, 2027, estimated from its own calendar.
What were Inhibrx Biosciences' latest quarterly earnings?
Inhibrx Biosciences reported diluted EPS of −2.46 and revenue of $2.0M on Nov 13, 2026.
How did Inhibrx Biosciences' stock move after its last earnings report?
Inhibrx Biosciences moved −6.8% in the session after its Nov 13, 2026 report.

